Contemporary Targeted Therapies in Rheumatology
eBook - PDF

Contemporary Targeted Therapies in Rheumatology

  1. 650 pages
  2. English
  3. PDF
  4. Available on iOS & Android
eBook - PDF

Contemporary Targeted Therapies in Rheumatology

About this book

Targeted therapies of rheumatic diseases have become a reality and have completely changed patient care as well as patient expectations. Initial success with therapies aimed at blocking TNF and IL-1 has stimulated the development of additional targeted approaches focused on other cytokines as well as specific cells and pathways involved in the path

Trusted by 375,005 students

Access to over 1.5 million titles for a fair monthly price.

Study more efficiently using our study tools.

Information

Publisher
CRC Press
Year
2007
Print ISBN
9781841844848
eBook ISBN
9780203694145
Edition
1
Topic
Medicine
Subtopic
Rheumatology, Orthopedics & Prosthetics

Table of contents

  1. Front Cover
  2. Title Page
  3. Contents
  4. Contributors
  5. Chapter 1- T cells – overview – update
  6. Chapter 02
  7. Chapter 2- Pathways of T-cell costimulation
  8. Chapter 3- Regulatory T cells
  9. Chapter 4- B-cell antigen receptor signaling and autoimmunity
  10. Chapter 5- Macrophages in rheumatoid arthritis
  11. Chapter 6- Dendritic cells
  12. Chapter 7- Osteoclasts
  13. Chapter 8- Cell contact dependence of inflammatory events
  14. Chapter 9- Toll-like receptors: possible targets for novel treatments for rheumatoid arthritis
  15. Chapter 10- Cadherin-11 mediates synovial lining organization: a new therapeutic target in inflammatory arthritis
  16. Chapter 11- TNF-α
  17. Chapter 12- Update on interleukin-6
  18. Chapter 13- Interleukin-13
  19. Chapter 14- Biology of interleukin-15
  20. Chapter 15- Interleukin-17: a new target in arthritis
  21. Chapter 16- The role of interleukin-18 in inflammation
  22. Chapter 17- Interleukin-21
  23. Chapter 18- The biology of human interleukin-32
  24. Chapter 19- The interferons
  25. Chapter 20- Osteoprotegerin
  26. Chapter 21- Update: inflammatory, angiogenic, and homeostatic chemokines and their receptors
  27. Chapter 22- New developments in NF-kB
  28. Chapter 23- Roles of the JAK-STAT signaling pathways in rheumatoid arthritis
  29. Chapter 24- Suppressor of cytokine signaling (SOCS)proteins as therapeutic targets in rheumatoid arthritis
  30. Chapter 25- Wnt signaling for targeted therapies in rheumatology
  31. Chapter 26- Inflammatory mediators: update on cyclooxygenases and prostaglandin synthases
  32. Chapter 27- Complement and pregnancy loss
  33. Chapter 28- Matrix metalloproteinases
  34. Chapter 29- MMPs and ADAMs as targets for therapies in arthritis
  35. Chapter 30- Update on proinflammatory cytokine blockade in rheumatoid arthritis
  36. Chapter 31- Targeting interleukin-1 in rheumatic diseases
  37. Chapter 32- Update on targeted therapy in psoriatic arthritis
  38. Chapter 33- Spondyloarthritides
  39. Chapter 34- Early Arthritis
  40. Chapter 35- Juvenile arthritis
  41. Chapter 36- Update – systemic lupus erythematosus
  42. Chapter 37- Vasculitis
  43. Chapter 38- Myositis
  44. Chapter 39- TNF blockade in orphan rheumatic diseases
  45. Chapter 40- Overview of the safety of TNF inhibitors
  46. Chapter 41- Anti-CD20 to further targeted therapies in rheumatology
  47. Chapter 42- Targeting B-lymphocyte stimulator(BLyS) in immune-based rheumatic diseases: a therapeutic promise waiting to be fulfilled
  48. Chapter 43- Anti-CD3 antibody – a history of successful immune interventions
  49. Chapter 44- Alefacept
  50. Chapter 45- Clinical targeting of interleukin-15
  51. Chapter 46- Clinical prospects of MAPK inhibitors
  52. Chapter 47- Clinical prospects of NF-κB inhibitors to further targeted therapies in rheumatology
  53. Chapter 48- Outcomes assessment in rheumatic disease
  54. Index
  55. Back Cover

Frequently asked questions

Yes, you can cancel anytime from the Subscription tab in your account settings on the Perlego website. Your subscription will stay active until the end of your current billing period. Learn how to cancel your subscription
No, books cannot be downloaded as external files, such as PDFs, for use outside of Perlego. However, you can download books within the Perlego app for offline reading on mobile or tablet. Learn how to download books offline
Perlego offers two plans: Essential and Complete
  • Essential is ideal for learners and professionals who enjoy exploring a wide range of subjects. Access the Essential Library with 800,000+ trusted titles and best-sellers across business, personal growth, and the humanities. Includes unlimited reading time and Standard Read Aloud voice.
  • Complete: Perfect for advanced learners and researchers needing full, unrestricted access. Unlock 1.5M+ books across hundreds of subjects, including academic and specialized titles. The Complete Plan also includes advanced features like Premium Read Aloud and Research Assistant.
Both plans are available with monthly, semester, or annual billing cycles.
We are an online textbook subscription service, where you can get access to an entire online library for less than the price of a single book per month. With over 1.5 million books across 990+ topics, we’ve got you covered! Learn about our mission
Look out for the read-aloud symbol on your next book to see if you can listen to it. The read-aloud tool reads text aloud for you, highlighting the text as it is being read. You can pause it, speed it up and slow it down. Learn more about Read Aloud
Yes! You can use the Perlego app on both iOS and Android devices to read anytime, anywhere — even offline. Perfect for commutes or when you’re on the go.
Please note we cannot support devices running on iOS 13 and Android 7 or earlier. Learn more about using the app
Yes, you can access Contemporary Targeted Therapies in Rheumatology by Josef S. Smolen, Peter E. Lipsky, Josef S. Smolen,Peter E. Lipsky in PDF and/or ePUB format, as well as other popular books in Medicine & Rheumatology, Orthopedics & Prosthetics. We have over 1.5 million books available in our catalogue for you to explore.